In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss: How ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

Mounting competition in the sector and rising obesity have led the pharmaceutical company to start selling the drug directly ...

Novo Nordisk A/S (NVO) has slashed prices for its blockbuster weight-loss drug Wegovy as competition in the obesity drug market heats up, with ...

Drinking artificially sweetened beverages may reduce metformin’s effectiveness in young patients with obesity and prediabetes ...

When her mother suggested she try a weight-loss drug ... If the group not taking the drug had benefited from the more intensive coaching, he believes the comparison would be fairer.

Eli Lilly stock surges past $840, outperforming the S&P 500. Click here to learn why LLY stock is still undervalued and why ...

The number of people in the UK who have died after taking drugs for diabetes and weight loss has risen to 82, according to new figures from the country’s medicines regulator. The Medicines and ...

Back in December, a stark warning was issued to Brits attempting to get their hands on weight loss drugs as officials spoke of the "tremendous" dangers of black market weight loss drugs. Still life of ...